Jianmin Pharmaceutical Group (600976.SS) Earnings Analysis

Jianmin Pharmaceutical Group (600976.SS) has no confirmed upcoming earnings date. Trailing P/E 13.09.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 600976.SS next report earnings?

No confirmed upcoming earnings date is currently scheduled for 600976.SS. This page updates as the calendar is published.

600976.SS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-180.57 CNYn/an/an/a
2026-03-210.48 CNYn/an/an/a
2025-10-210.4245 CNYn/an/an/a
2025-04-180.73 CNYn/an/an/a
2025-03-210.2666 CNYn/an/an/a
2024-10-180.536 CNYn/an/an/a
2024-08-150.913 CNYn/an/an/a

600976.SS valuation and analyst view

Trailing P/E13.09
Trailing EPS2.199 CNY
Price / book1.61
Dividend yield3.13%
Market cap4.46B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Jianmin Pharmaceutical Group (600976.SS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 600976.SS. This page updates as the calendar is published.

Did 600976.SS beat earnings last quarter?

Consensus estimate data was not available for 600976.SS's 2026-04-18 report.

What is 600976.SS's current P/E ratio and EPS?

600976.SS trades at a trailing P/E of 13.09 on trailing EPS of 2.1994759078635657 CNY.

What do analysts rate 600976.SS?

600976.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.